At Imbria, our mission is to translate our understanding of cellular metabolism into medicines that improve the lives of patients with limited or inadequate treatment options.
Developing new treatments for cardiac disorders
Developing new treatments for rare inborn errors of metabolism
Rare inborn errors of metabolism
Diseases that arise from inborn errors of metabolism are characterized by deficiencies in metabolic enzymes that alter the production of substrates that are critical for proper functioning of the tricarboxylic acid, or TCA, cycle, a central pathway used to extract energy stored in carbohydrates, fats, and proteins into forms that can be used by cells.